Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1962 Mar;21(1):70–75. doi: 10.1136/ard.21.1.70

Lupus Erythematosus Cells in Systemic Sclerosis

N R Rowell 1
PMCID: PMC1007255  PMID: 14494658

Full text

PDF
70

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARNOLD H. L., Jr, TILDEN I. L. Fatal scleroderma with L. E. phenomenon; report of a case. AMA Arch Derm. 1957 Oct;76(4):427–430. doi: 10.1001/archderm.1957.01550220035006. [DOI] [PubMed] [Google Scholar]
  2. BARDAWIL W. A., TOY B. L., GALINS N., BAYLES T. B. Disseminated lupus erythematosus, scleroderma, and dermatomyositis as manifestations of sensitization to DNA-protein. I. An immunohistochemical approach. Am J Pathol. 1958 Jul-Aug;34(4):607–629. [PMC free article] [PubMed] [Google Scholar]
  3. BARTHOLOMEW L. G., HAGEDORN A. B., CAIN J. C., BAGGENSTOSS A. H. Hepatitis and cirrhosis in women with positive clot tests for lupus erythematosus. N Engl J Med. 1958 Nov 13;259(20):947–956. doi: 10.1056/NEJM195811132592001. [DOI] [PubMed] [Google Scholar]
  4. BEARN A. G., KUNKEL H. G., SLATER R. J. The problem of chronic liver disease in young women. Am J Med. 1956 Jul;21(1):3–15. doi: 10.1016/0002-9343(56)90003-1. [DOI] [PubMed] [Google Scholar]
  5. BERMAN L., AXELROD A. R., GOODMAN H. L., McCLAUGHRY R. I. So-called "lupus erythematosus inclusion phenomenon" of bone marrow and blood. Am J Clin Pathol. 1950 May;20(5):403–418. doi: 10.1093/ajcp/20.5.403. [DOI] [PubMed] [Google Scholar]
  6. BLACK A., GOLDIN M., POSKE R. M., MALMED L. Differentiation between rheumatoid arthritis and systemic lupus erythematosus by sheep cell agglutination tests. Arthritis Rheum. 1959 Apr;2(2):99–103. doi: 10.1002/1529-0131(195904)2:2<99::aid-art1780020202>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  7. Bevans M. Pathology of Scleroderma, with Special Reference to the Changes in the Gastrointestinal Tract. Am J Pathol. 1945 Jan;21(1):25–51. [PMC free article] [PubMed] [Google Scholar]
  8. DOMZ C. A., McNAMARA D. H., HOLZAPFEL H. F. Tetracycline provocation in lupus erythematosus. Ann Intern Med. 1959 May;50(5):1217–1226. doi: 10.7326/0003-4819-50-5-1217. [DOI] [PubMed] [Google Scholar]
  9. DUBOIS E. L. Acquired hemolytic anemias the presenting syndrome of lupus erythematosus disseminatus. Am J Med. 1952 Feb;12(2):197–204. doi: 10.1016/0002-9343(52)90212-x. [DOI] [PubMed] [Google Scholar]
  10. EATON L. M. The perspective of neurology in regard to polymyositis; a study of 41 cases. Neurology. 1954 Apr;4(4):245–263. doi: 10.1212/wnl.4.4.245. [DOI] [PubMed] [Google Scholar]
  11. FARMER R. G., COOPER T., PASCUZZI C. A. Cryoglobulinemia. Report of twelve cases with bone marrow findings. Arch Intern Med. 1960 Oct;106:483–495. doi: 10.1001/archinte.1960.03820040021004. [DOI] [PubMed] [Google Scholar]
  12. GAUSEWITZ P. L., JONES F. S., WORLEY G., Jr Fatal generalized moniliasis; report of a case. Am J Clin Pathol. 1951 Jan;21(1):41–49. doi: 10.1093/ajcp/21.1.41. [DOI] [PubMed] [Google Scholar]
  13. GOLD S. Role of sulphonamides and penicillin in the pathogenesis of systemic lupus erythematosus. Lancet. 1951 Feb 3;1(6649):268–272. doi: 10.1016/s0140-6736(51)93319-3. [DOI] [PubMed] [Google Scholar]
  14. HALL A. P., BARDAWIL W. A., BAYLES T. B., MEDNIS A. D., GALINS N. The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases. N Engl J Med. 1960 Oct 20;263:769–775. doi: 10.1056/NEJM196010202631601. [DOI] [PubMed] [Google Scholar]
  15. HASERICK J. R. Simulation of the lupus erythematosus phenomenon by materials of fungal origin. J Invest Dermatol. 1951 Apr;16(4):211–215. doi: 10.1038/jid.1951.29. [DOI] [PubMed] [Google Scholar]
  16. HEATON J. M. Sjögren's syndrome and systemic lupus erythematosus. Br Med J. 1959 Feb 21;1(5120):466–469. doi: 10.1136/bmj.1.5120.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HELLER P., YAKULIS V., GLICK M. L., KRASNOW S. E. Phagocytosis of cryoglobulin: observations on crystal-inclusion cells. Am J Med Sci. 1958 Aug;236(2):208–224. doi: 10.1097/00000441-195808000-00010. [DOI] [PubMed] [Google Scholar]
  18. HELLER P., ZIMMERMAN H. J., ROZENGVAIG S., SINGER K. The L.E.-cell phenomenon in chronic hepatic disease. N Engl J Med. 1956 Jun 21;254(25):1160–1165. doi: 10.1056/NEJM195606212542503. [DOI] [PubMed] [Google Scholar]
  19. HUTCHINSON J. H., HOWELL R. A. Cryoglobulinemia: report of a case associated with gangrene of the digits. Ann Intern Med. 1953 Aug;39(2):350–357. doi: 10.7326/0003-4819-39-2-350. [DOI] [PubMed] [Google Scholar]
  20. JACOBS A. G. A false-positive lupus erythematosus test. Ann Intern Med. 1955 May;42(5):1097–1100. doi: 10.7326/0003-4819-42-5-1097. [DOI] [PubMed] [Google Scholar]
  21. JOSKE R. A., KING W. E. The L.E.-cell phenomenon in active chronic viral hepatitis. Lancet. 1955 Sep 3;269(6888):477–480. doi: 10.1016/s0140-6736(55)93331-6. [DOI] [PubMed] [Google Scholar]
  22. LINCOLN M., RICKER W. A. A case of periarteritis nodosa with L.E. cells; apparent complete remission with cortisone therapy. Ann Intern Med. 1954 Sep;41(3):639–646. doi: 10.7326/0003-4819-41-3-639. [DOI] [PubMed] [Google Scholar]
  23. MACKAY I. R., TAFT L. I., COWLING D. C. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet. 1959 Jan 10;1(7063):65–69. doi: 10.1016/s0140-6736(59)91136-5. [DOI] [PubMed] [Google Scholar]
  24. MARTEN R. H., BLACKBURN E. K. Lupus erythematosus; clinical and hematological studies in seventy-seven cases. AMA Arch Derm. 1956 Jan;73(1):1–14. doi: 10.1001/archderm.1956.01550010003001. [DOI] [PubMed] [Google Scholar]
  25. MILLER R., Jr, HORGAN J. T. Lupus erythematosus cells in scleroderma. Report of a case and analysis of the phenomenon. U S Armed Forces Med J. 1960 Feb;11:140–151. [PubMed] [Google Scholar]
  26. MORROW J. D., SCHROEDER H. A., PERRY H. M., Jr Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects. Circulation. 1953 Dec;8(6):829–839. doi: 10.1161/01.cir.8.6.829. [DOI] [PubMed] [Google Scholar]
  27. MUEHRCKE R. C., KARK R. M., PIRANI C. L., POLLAK V. E. Lupus nephritis: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore) 1957 Feb;36(1):1–145. [PubMed] [Google Scholar]
  28. PARELHOFF M. E. Demonstration of the L. E. cell phenomenon in subacute glomerulonephritis. Sinai Hosp J (Balt) 1953 Nov;2(2):12–20. [PubMed] [Google Scholar]
  29. PERRY H. M., Jr, SCHROEDER H. A. Syndrome simulating collagen disease caused by hydralazine (Apresoline). J Am Med Assoc. 1954 Feb 20;154(8):670–673. doi: 10.1001/jama.1954.02940420032009. [DOI] [PubMed] [Google Scholar]
  30. REBUCK J. W., BERMAN L. Experimental production of the L. E. phenomenon in the skin of man. Proc Soc Exp Biol Med. 1950 Oct;75(1):259–264. doi: 10.3181/00379727-75-18165. [DOI] [PubMed] [Google Scholar]
  31. REINHARDT D. J., WALDRON J. M. Lupus erythematosus-like syndrome complicating hydralazine (apresoline) therapy. J Am Med Assoc. 1954 Aug 21;155(17):1491–1492. doi: 10.1001/jama.1954.73690350001010. [DOI] [PubMed] [Google Scholar]
  32. SHACKMAN N. H., SWILLER A. I., MORRISON M. Syndrome simulating acute disseminated lupus erythematosus: appearance after hydralazine (apresoline) therapy. J Am Med Assoc. 1954 Aug 21;155(17):1492–1494. doi: 10.1001/jama.1954.73690350002010a. [DOI] [PubMed] [Google Scholar]
  33. SIEGEL B. M., FRIEDMAN I. A., KESSLER S., SCHWARTZ S. O. Thrombohemolytic thrombocytopenic purpura and lupus erythematosus. Ann Intern Med. 1957 Nov;47(5):1022–1029. doi: 10.7326/0003-4819-47-5-1022. [DOI] [PubMed] [Google Scholar]
  34. SLOCUMB C. H. Rheumatic complaints during chronic hypercortisonism and syndromes during withdrawal of cortisone in rheumatic patients. Proc Staff Meet Mayo Clin. 1953 Nov 18;28(23):655–657. [PubMed] [Google Scholar]
  35. TRUBOWITZ S. The sternal marrow aspiration of amyloid in multiple myeloma. Blood. 1950 Jun;5(6):581–585. [PubMed] [Google Scholar]
  36. VOLPE R., HAUCH J. T. A case of scleroderma with L.E. cells and prolonged remission on cortisone therapy. Can Med Assoc J. 1955 Apr 15;72(8):597–599. [PMC free article] [PubMed] [Google Scholar]
  37. VOLPE R., OGRYZLO M. A. The cryoglobulin inclusion cell. Blood. 1955 May;10(5):493–496. [PubMed] [Google Scholar]
  38. WALSH J. R., ZIMMERMAN H. J. The demonstration of the L.E. phenomenon in patients with penicillin hypersensitivity. Blood. 1953 Jan;8(1):65–71. [PubMed] [Google Scholar]
  39. WATSON J. B., O'LEARY P. A., HARGRAVES M. M. Neutrophils resembling L. E. cells in artificial blisters. AMA Arch Derm Syphilol. 1951 Mar;63(3):328–333. doi: 10.1001/archderm.1951.01570030042004. [DOI] [PubMed] [Google Scholar]
  40. WEISS R. S., SWIFT S. The significance of a positive L. E. phenomenon. AMA Arch Derm. 1955 Aug;72(2):103–112. doi: 10.1001/archderm.1955.03730320001001. [DOI] [PubMed] [Google Scholar]
  41. WILKINSON M., SACKER L. S. The lupus erythematosus cell and its significance. Br Med J. 1957 Sep 21;2(5046):661–665. doi: 10.1136/bmj.2.5046.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. ZIMMER F. E., HARGRAVES M. M. The effect of blood coagulation on L.E. cell formation. Proc Staff Meet Mayo Clin. 1952 Oct 22;27(22):424–430. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES